|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Current assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Deferred offering costs | |||||
| Long-term prepaid insurance | |||||
| Marketable securities held in Trust Account | |||||
| Total Assets | |||||
| Current Liabilities | |||||
| Accrued offering costs | |||||
| Accrued expenses | |||||
| Promissory note - related party | |||||
| Total Current Liabilities | |||||
| Deferred underwriting fee | |||||
| Total liabilities | |||||
| Class A ordinary shares subject to possible redemption, 25,300,000 shares at redemption value of $10.36 and $10.18 per share at June 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Deficit | |||||
| Ordinary shares, value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
Loading...
